Association Between ICDs and Aggressive End-of-Life Care in Advanced Cancer
Obe-Cel Induces Durable Remissions in Adult Relapsed/Refractory B-Cell ALL
FDA Approves Datopotamab Deruxtecan for Advanced Breast Cancer
Adding Lenvatinib/Pembrolizumab to TACE Extends PFS in Unresectable Liver Cancer